Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Underutilization of A2 ABO incompatible kidney transplantation.

Redfield RR, Parsons RF, Rodriguez E, Mustafa M, Cassuto J, Vivek K, Noorchashm H, Naji A, Levine MH, Abt PL.

Clin Transplant. 2012 May-Jun;26(3):489-94. doi: 10.1111/j.1399-0012.2011.01543.x. Epub 2011 Oct 27.

2.

A2 incompatible kidney transplantation does not adversely affect graft or patient survival.

Forbes RC, Feurer ID, Shaffer D.

Clin Transplant. 2016 May;30(5):589-97. doi: 10.1111/ctr.12724. Epub 2016 Mar 17.

PMID:
26913566
3.

First Report on the OPTN National Variance: Allocation of A2 /A2 B Deceased Donor Kidneys to Blood Group B Increases Minority Transplantation.

Williams WW, Cherikh WS, Young CJ, Fan PY, Cheng Y, Distant DA, Bryan CF.

Am J Transplant. 2015 Dec;15(12):3134-42. doi: 10.1111/ajt.13409. Epub 2015 Aug 4.

4.

Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.

Tanabe K, Takahashi K, Sonda K, Tokumoto T, Ishikawa N, Kawai T, Fuchinoue S, Oshima T, Yagisawa T, Nakazawa H, Goya N, Koga S, Kawaguchi H, Ito K, Toma H, Agishi T, Ota K.

Transplantation. 1998 Jan 27;65(2):224-8.

PMID:
9458019
5.

ABO incompatible kidney transplantation - an analysis of UNOS Registry data.

Futagawa Y, Terasaki PI.

Clin Transplant. 2006 Jan-Feb;20(1):122-6.

PMID:
16556166
6.

Transplantation of ABO A2 kidneys into O recipients: do IgM anti-A1 titers matter?

Tierney J, Shaffer D.

Clin Transplant. 2015 Apr;29(4):379-82. doi: 10.1111/ctr.12527. Epub 2015 Feb 26.

PMID:
25659826
7.

ABO-incompatibility in solid organ transplantation.

Rydberg L.

Transfus Med. 2001 Aug;11(4):325-42. Review.

PMID:
11532188
8.

Present status of ABO-incompatible kidney transplantation in Japan.

Takahashi K, Saito K.

Xenotransplantation. 2006 Mar;13(2):118-22.

PMID:
16623804
9.

Current experience with renal transplantation across the ABO barrier.

Nelson PW, Helling TS, Shield CF, Beck M, Bryan CF.

Am J Surg. 1992 Nov;164(5):541-4; discussion 544-5.

PMID:
1443385
10.

Adult ABO-incompatible liver transplantation, using A and B donors.

Skogsberg U, Breimer ME, Friman S, Mjörnstedt L, Mölne J, Olausson M, Rydberg L, Svalander CT, Bäckman L.

Xenotransplantation. 2006 Mar;13(2):154-9.

PMID:
16623811
11.

Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.

Opelz G, Morath C, Süsal C, Tran TH, Zeier M, Döhler B.

Transplantation. 2015 Feb;99(2):400-4. doi: 10.1097/TP.0000000000000312.

PMID:
25050471
12.

Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients.

Sharif A, Alachkar N, Bagnasco S, Geetha D, Gupta G, Womer K, Arend L, Racusen L, Montgomery R, Kraus E.

Clin J Am Soc Nephrol. 2012 Aug;7(8):1320-7. doi: 10.2215/CJN.00770112. Epub 2012 May 24.

13.

Safety of blood group A2-to-O liver transplantation: an analysis of the United Network of Organ Sharing database.

Kluger MD, Guarrera JV, Olsen SK, Brown RS Jr, Emond JC, Cherqui D.

Transplantation. 2012 Sep 15;94(5):526-31.

PMID:
22874840
14.

Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients.

Bryan CF, Winklhofer FT, Murillo D, Ross G, Nelson PW, Shield CF 3rd, Warady BA.

Transplantation. 2005 Jul 15;80(1):75-80.

PMID:
16003236
15.

Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate.

Bryan CF, Nelson PW, Shield CF 3rd, Ross G, Warady B, Murillo D, Winklhofer FT.

Clin Transpl. 2004:127-33.

PMID:
16704145
16.

Impact of HLA-identity on results of ABO-incompatible living kidney transplantation.

Shimmura H, Tanabe K, Tokumoto T, Ishida H, Ishikawa N, Miyamoto N, Shimizu T, Shirakawa H, Setoguchi K, Teraoka S, Toma H.

Transplant Proc. 2004 Sep;36(7):2172-4.

PMID:
15518790
17.

Impact of ABO compatibility on outcomes after heart transplantation in a national cohort during the past decade.

Jawitz OK, G Jawitz N, Yuh DD, Bonde P.

J Thorac Cardiovasc Surg. 2013 Nov;146(5):1239-45; discussion 1245-6. doi: 10.1016/j.jtcvs.2013.06.040. Epub 2013 Aug 24.

18.

Transplantation of A2 kidneys into B and O recipients leads to reduction in waiting time: USRDS experience.

Hurst FP, Sajjad I, Elster EA, Falta EM, Patel P, Abbott KC, Agodoa LY, Jindal RM.

Transplantation. 2010 Jun 15;89(11):1396-402. doi: 10.1097/TP.0b013e3181da191a.

PMID:
20354481
19.

Eight years of outcomes of the Dutch Living Donor Kidney Exchange Program.

de Klerk M, Kal-van Gestel JA, Haase-Kromwijk BJ, Claas FH, Weimar W; Living Donor Kidney Exchange Program.

Clin Transpl. 2011:287-90.

PMID:
22755421
20.

ABO-Incompatible Living Kidney Transplants: Evolution of Outcomes and Immunosuppressive Management.

Okumi M, Toki D, Nozaki T, Shimizu T, Shirakawa H, Omoto K, Inui M, Ishida H, Tanabe K.

Am J Transplant. 2016 Mar;16(3):886-96. doi: 10.1111/ajt.13502. Epub 2015 Nov 10.

Supplemental Content

Support Center